Shares of Rapport Therapeutics Inc. (RAPP) are trading at over a 30% discount to their 52-week high of $42.27, recorded last September, as the company advances its precision neuroscience pipeline, positioning it as a potential leader in epilepsy and a biotech story to watch.Company ProfileRapport Therapeutics is a clinical-stage biotechnology company developing small-molecule precision medicines f...
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.